PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SPD vs. XBI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


SPDXBI
YTD Return21.61%16.84%
1Y Return33.02%56.69%
3Y Return (Ann)3.57%-6.75%
Sharpe Ratio2.921.89
Sortino Ratio4.082.60
Omega Ratio1.541.31
Calmar Ratio1.740.81
Martin Ratio16.876.53
Ulcer Index1.91%7.70%
Daily Std Dev11.03%26.60%
Max Drawdown-27.38%-63.89%
Current Drawdown0.00%-40.01%

Correlation

-0.50.00.51.00.5

The correlation between SPD and XBI is 0.49, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

SPD vs. XBI - Performance Comparison

In the year-to-date period, SPD achieves a 21.61% return, which is significantly higher than XBI's 16.84% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%5.00%10.00%15.00%20.00%JuneJulyAugustSeptemberOctoberNovember
11.79%
18.35%
SPD
XBI

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


SPD vs. XBI - Expense Ratio Comparison

SPD has a 0.28% expense ratio, which is lower than XBI's 0.35% expense ratio.


XBI
SPDR S&P Biotech ETF
Expense ratio chart for XBI: current value at 0.35% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.35%
Expense ratio chart for SPD: current value at 0.28% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.28%

Risk-Adjusted Performance

SPD vs. XBI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Simplify US Equity PLUS Downside Convexity ETF (SPD) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SPD
Sharpe ratio
The chart of Sharpe ratio for SPD, currently valued at 2.92, compared to the broader market-2.000.002.004.002.92
Sortino ratio
The chart of Sortino ratio for SPD, currently valued at 4.08, compared to the broader market0.005.0010.004.08
Omega ratio
The chart of Omega ratio for SPD, currently valued at 1.54, compared to the broader market1.001.502.002.503.001.54
Calmar ratio
The chart of Calmar ratio for SPD, currently valued at 1.74, compared to the broader market0.005.0010.0015.001.74
Martin ratio
The chart of Martin ratio for SPD, currently valued at 16.87, compared to the broader market0.0020.0040.0060.0080.00100.00120.0016.87
XBI
Sharpe ratio
The chart of Sharpe ratio for XBI, currently valued at 1.89, compared to the broader market-2.000.002.004.001.89
Sortino ratio
The chart of Sortino ratio for XBI, currently valued at 2.60, compared to the broader market0.005.0010.002.60
Omega ratio
The chart of Omega ratio for XBI, currently valued at 1.31, compared to the broader market1.001.502.002.503.001.31
Calmar ratio
The chart of Calmar ratio for XBI, currently valued at 0.81, compared to the broader market0.005.0010.0015.000.81
Martin ratio
The chart of Martin ratio for XBI, currently valued at 6.53, compared to the broader market0.0020.0040.0060.0080.00100.00120.006.53

SPD vs. XBI - Sharpe Ratio Comparison

The current SPD Sharpe Ratio is 2.92, which is higher than the XBI Sharpe Ratio of 1.89. The chart below compares the historical Sharpe Ratios of SPD and XBI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.503.003.50JuneJulyAugustSeptemberOctoberNovember
2.92
1.89
SPD
XBI

Dividends

SPD vs. XBI - Dividend Comparison

SPD's dividend yield for the trailing twelve months is around 1.26%, more than XBI's 0.14% yield.


TTM20232022202120202019201820172016201520142013
SPD
Simplify US Equity PLUS Downside Convexity ETF
1.26%1.91%1.65%0.88%0.43%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
XBI
SPDR S&P Biotech ETF
0.14%0.02%0.00%0.04%0.20%0.00%0.28%0.24%0.26%0.61%1.07%0.17%

Drawdowns

SPD vs. XBI - Drawdown Comparison

The maximum SPD drawdown since its inception was -27.38%, smaller than the maximum XBI drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for SPD and XBI. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JuneJulyAugustSeptemberOctoberNovember0
-40.01%
SPD
XBI

Volatility

SPD vs. XBI - Volatility Comparison

The current volatility for Simplify US Equity PLUS Downside Convexity ETF (SPD) is 3.58%, while SPDR S&P Biotech ETF (XBI) has a volatility of 5.37%. This indicates that SPD experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%8.00%JuneJulyAugustSeptemberOctoberNovember
3.58%
5.37%
SPD
XBI